loadpatents
Patent applications and USPTO patent grants for Willette; Robert Nicholas.The latest application filed is for "nicotinamide derivate in the treatment of acute coronary syndrome".
Patent | Date |
---|---|
Losmapimod for use in treating glomerular disease Grant 9,707,219 - Sprecher , et al. July 18, 2 | 2017-07-18 |
Nicotinamide Derivate In The Treatment Of Acute Coronary Syndrome App 20160367542 - Ghirardi; Michele ;   et al. | 2016-12-22 |
Losmapimod For Use In Treating Glomerular Disease App 20160220550 - SPRECHER; Dennis ;   et al. | 2016-08-04 |
Nicotinamide Derivate In The Treatment Of Acute Coronary Syndrome App 20150209337 - Ghirardi; Michele ;   et al. | 2015-07-30 |
Pharmaceutical Composition Containing Bicyclic Type Compounds App 20100099752 - Chan; Wai Ngor ;   et al. | 2010-04-22 |
Pharmaceutical Composition Containing Bicyclic Type Compounds App 20070088064 - Chan; Wai Ngor ;   et al. | 2007-04-19 |
Pharmaceutical composition containing bicyclic type compounds App 20030236410 - Chan, Wai Ngor ;   et al. | 2003-12-25 |
Pharmaceutical composition containing bicyclic type compounds App 20020123630 - Chan, Wai Ngor ;   et al. | 2002-09-05 |
Pharmaceutical composition containing bicyclic type compounds App 20010021780 - Chan, Wai Ngor ;   et al. | 2001-09-13 |
Pharmaceutical composition containing bicyclic type compounds Grant 5,948,811 - Chan , et al. September 7, 1 | 1999-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.